• to lower the chance of really serious cardiovascular (heart and blood vessel) complications in Older people with variety two diabetes and cardiovascular diseaseThis led Novo Nordisk to perform additional investigation into better dosages of semaglutide specifically for weight administration.significant allergic reactions. End applying Wegovy®